Pinterest to Participate in the Goldman Sachs Communacopia + Technology Conference
Pinterest to Participate in the Goldman Sachs Communacopia + Technology Conference
Pinterest, Inc. (NYSE: PINS) announced today that Bill Ready, CEO, will participate in the Goldman Sachs Communacopia + Technology Conference. The session is scheduled for September 11, 2024 at 8:10 a.m PT / 11:10 a.m. ET.
A live webcast and replay of the presentation will be publicly available on Pinterest’s Investor Relations website at investor.pinterestinc.com.
Disclosure Information
Pinterest uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the company’s Investor Relations website, in addition to following the company’s press releases, SEC filings, public conference calls, presentations and webcasts.
About Pinterest
Pinterest is a visual search and discovery platform where people find inspiration, curate ideas, and shop products—all in a positive place online. Headquartered in San Francisco, Pinterest launched in 2010 and has over half a billion monthly active users worldwide.
Press
Tessa Chen
press@pinterest.com
Investor Relations
Andrew Somberg
ir@pinterest.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240801633933/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks